Indonesia HIV/AIDS Adult Prevalence Rate 2024: 0.40 %
Indonesia's hiv/aids adult prevalence rate in 2024 is 0.40 %, unchanged from 2023. It ranks #69 of 148 countries.
HIV/AIDS Adult Prevalence Rate reveals the percentage of adults affected. Compare countries, explore rankings, and view historical trends.
Source (2024): Prevalence of HIV, total (% of population ages 15-49), World Bank (WB)
Where Indonesia ranks (2024)
#69 of 148- #69
Eritrea0.4%
- #69
Georgia0.4%
- #69
Indonesia0.4%
- #69
Laos0.4%
- #69
Peru0.4%
HIV/AIDS Adult Prevalence Rate over time
| Year | Value | Change | % Change | Actions |
|---|---|---|---|---|
| 2024 | 0.4 % | 0 % | 0.00% | |
| 2023 | 0.4 % | 0 % | 0.00% | |
| 2022 | 0.4 % | 0 % | 0.00% | |
| 2021 | 0.4 % | 0 % | 0.00% | |
| 2020 | 0.4 % | 0 % | 0.00% | |
| 2019 | 0.4 % | 0 % | 0.00% | |
| 2018 | 0.4 % | 0 % | 0.00% | |
| 2017 | 0.4 % | 0 % | 0.00% | |
| 2016 | 0.4 % | 0 % | 0.00% | |
| 2015 | 0.4 % | 0 % | 0.00% | |
| 2014 | 0.4 % | +0.1 % | +33.33% | |
| 2013 | 0.3 % | 0 % | 0.00% | |
| 2012 | 0.3 % | 0 % | 0.00% | |
| 2011 | 0.3 % | 0 % | 0.00% | |
| 2010 | 0.3 % | 0 % | 0.00% | |
| 2009 | 0.3 % | 0 % | 0.00% | |
| 2008 | 0.3 % | +0.1 % | +50.00% | |
| 2007 | 0.2 % | 0 % | 0.00% | |
| 2006 | 0.2 % | 0 % | 0.00% | |
| 2005 | 0.2 % | +0.1 % | +100.00% | |
| 2004 | 0.1 % | 0 % | 0.00% | |
| 2003 | 0.1 % | 0 % | 0.00% | |
| 2002 | 0.1 % | 0 % | 0.00% | |
| 2001 | 0.1 % | 0 % | 0.00% | |
| 2000 | 0.1 % | 0 % | 0.00% | |
| 1999 | 0.1 % | 0 % | 0.00% | |
| 1998 | 0.1 % | 0 % | 0.00% | |
| 1997 | 0.1 % | 0 % | 0.00% | |
| 1996 | 0.1 % | 0 % | 0.00% | |
| 1995 | 0.1 % | 0 % | 0.00% | |
| 1994 | 0.1 % | 0 % | 0.00% | |
| 1993 | 0.1 % | 0 % | 0.00% | |
| 1992 | 0.1 % | 0 % | 0.00% | |
| 1991 | 0.1 % | 0 % | 0.00% | |
| 1990 | 0.1 % | — | — |
Cite this page
Geo Factbook. (n.d.). Indonesia: HIV/AIDS Adult Prevalence Rate. Retrieved November 20, 2026, from https://geofactbook.com/countries/indonesia/hivaids-adult-prevalence-rate
The figures on this page come from Prevalence of HIV, total (% of population ages 15-49) | UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS) via World Bank. For academic work, cite the original source as well.
Frequently Asked Questions About Indonesia HIV/AIDS Adult Prevalence Rate
What is Indonesia's hiv/aids adult prevalence rate in 2024?▾
Indonesia's hiv/aids adult prevalence rate is 0.40 % in 2024, according to Prevalence of HIV, total (% of population ages 15-49) | UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS) via World Bank.
Is Indonesia's hiv/aids adult prevalence rate increasing or decreasing?▾
Indonesia's hiv/aids adult prevalence rate was essentially unchanged from 2023 (0.40 %) to 2024 (0.40 %). Over the past decade (2014–2024) it was essentially unchanged.
How does Indonesia rank for hiv/aids adult prevalence rate?▾
In 2024, Indonesia has the 69th highest hiv/aids adult prevalence rate out of 148 countries with data.
What was Indonesia's hiv/aids adult prevalence rate in 1990?▾
In 1990, Indonesia's hiv/aids adult prevalence rate was 0.10 %. By 2024 it rose by 300.0%.
Explore additional statistical insights
Psychiatrist Density Per 100,000 People in Indonesia
Psychiatrist density measures the number of psychiatrists available per 100,000 people, indicating mental health access.
Male Smoking Prevalence in Indonesia
Male smoking prevalence indicates the percentage of men who smoke in each country. Understand global trends and health impacts.
Parkinson's Disease Mortality Rate in Indonesia
Parkinson's disease mortality rate shows the number of deaths due to the disease per 100,000 people annually.
Nurses and Midwives Density in Indonesia
Nurses and midwives density measures healthcare accessibility. Learn about countries with the highest and lowest density per 1,000 people.
Female Life Expectancy Leaders in Indonesia
Explore which countries lead in female life expectancy. Japan and Switzerland often top the list.
Pharmacists Density in Indonesia
Pharmacists density indicates healthcare accessibility; a higher number suggests better pharmaceutical services per 10,000 people.